I submitted some questions although doubt they will answer any of these. Thanks for the link beartrap
Hi I am XXXXXXXXXXX a long time investor in NWBO. I have the following questions I would like to submit for discussion at the ASM. (1) Is MHRA approval expected soon and why has it taken so long? (2) Is approval anticipated only for DCVAX-L for GBM or will it be for DCVAX-L for other solid tumor cancers as well? (3) I thought NWBO had announced that DCVAX-Direct phase-3 was going to start earlier in 2025. It has not yet started so is it going to happen and when? (4) How much longer is it going to take to have Flaskworks fully automated closed system manufacturing approved, on-line and operational? Are we still working out some issues with functionality and when would we hope to submit it for approval? That is probably enough tough questions that may be difficult to answer.